Suven Pharmaceuticals renamed as Cohance Lifesciences

Suven Pharmaceuticals announced that the Ministry of Corporate Affairs, Government of India (MCA), has approved change of name of the Company from Suven Pharmaceuticals to Cohance Lifesciences, with effect from 07 May 2025. The change of name has been carried on pursuant to the Scheme of Amalgamation.

“The transition to Cohance Lifesciences marks a pivotal moment in our commitment to better serve our customers and their end market. We are building a global CDMO that aims to enable innovation across a broad range of modalities, chemistries, and technologies, to advance solutions for a healthier world ” said Cohance Executive Chairman, Vivek Sharma.

Related Posts

  • Pharma
  • June 6, 2025
  • 257 views
Wockhardt’s novel antibiotic Zaynich eyes $9 billion global market

Mumbai-based pharma major Wockhardt, which is all set to launch its new class of antibiotic Zaynich targeted at treating complicated gram-negative infections in India this year, estimates that the drug…

  • Pharma
  • June 6, 2025
  • 153 views
Fake cosmetics racket busted in Bhubaneswar’s Unit-1 Market

In a joint crackdown, Odisha’s Drugs Control administration and Crime Branch Special Task Force (STF) raided Unit-1 Market in Bhubaneswar on Thursday, seizing duplicate cosmetic products sold under top brand…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Wockhardt’s novel antibiotic Zaynich eyes $9 billion global market

Wockhardt’s novel antibiotic Zaynich eyes $9 billion global market

Fake cosmetics racket busted in Bhubaneswar’s Unit-1 Market

Fake cosmetics racket busted in Bhubaneswar’s Unit-1 Market

Illegally stocked drugs worth Rs 5.21 lakh seized

Illegally stocked drugs worth Rs 5.21 lakh seized

Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions

Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions